de-risk discovery

accelerate opportunity

de-risk discovery

accelerate opportunity

Cambridge Biocapital is the premier strategic advisory firm dedicated to navigating the complex landscape at the intersection of life sciences innovation, investment, and commercialisation.

About us

In an environment defined by rapid scientific advancement, complex funding cycles, and evolving market dynamics, securing expert guidance is critical.

We partner with universities, research institutions and governments to unlock the value of scientific discovery and accelerate translation.

We provide the specialised insights, strategic counsel, and execution support necessary to achieve success in the global health and life sciences ecosystem.

Our services

Tech Transfer Strategy

We design and implement tailored regulatory and IP frameworks, alongside spinout policies and institutional training plans to improve knowledge transfer

Technology Evaluation

We assess the technical and commercial potential, and competitive edge of early-stage innovation to guide decision making

Ecosystem Access

We connect our partners to our European life sciences innovation network providing access to best practices and international markets

Proof-of-Concept Support

We provide strategic project management to achieve critical validation milestones and demonstrate commercial potential

Knowledge + action

We design tailored institutional strategies to improve spinout creation and success

News

Press release

Cambridge Biocapital Launches to Spearhead European Health Technology Transfer with Landmark €1.3M EIT Health ‘Healthpreneurs’ Consortium

June 24, 2025

Read more